ACTA2: Actin Alpha 2, Smooth Muscle

Key regulator of smooth muscle contraction and vascular integrity; mutations linked to aortic aneurysms and multisystemic smooth muscle dysfunction.

Gene Information Card

Symbol ACTA2
Full Name Actin Alpha 2, Smooth Muscle
Gene Type Protein coding
Chromosomal Location 10q23.31
NCBI Gene ID 59 ncbi.nlm.nih.gov/gene/59
Ensembl ID ENSG00000107796
UniProt ID P62736
OMIM ID 102620
HGNC ID 130
Aliases ACTSA, ACTVS, alpha-actin-2, smooth muscle alpha-actin

Description

ACTA2 encodes alpha-actin-2, a major component of the contractile apparatus in smooth muscle cells. This protein is essential for vascular smooth muscle contraction and maintenance of arterial integrity. Mutations in ACTA2 are a common cause of familial thoracic aortic aneurysms and dissections (TAAD) and are associated with multisystemic smooth muscle dysfunction syndrome (MSMDS).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thoracic Aortic Aneurysm and Dissection (TAAD) Missense mutations disrupt actin polymerization and contractile function, weakening the aortic wall. ClinVar, OMIM
Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) Loss-of-function or dominant-negative mutations impair smooth muscle contraction in multiple organs, leading to vascular, gastrointestinal, and pulmonary complications. OMIM, NCBI
Moyamoya Disease Specific ACTA2 mutations (e.g., p.Arg179His) predispose to cerebrovascular occlusive disease. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Artery 124.5 High
Uterus 78.3 High
Stomach 65.2 High
Bladder 52.1 High
Lung 12.4 Medium
Heart 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
Aortic Smooth Muscle Cells 145.2 Primary cell type
Uterine Smooth Muscle Cells 88.7 High expression
Bronchial Smooth Muscle Cells 42.3 Moderate expression
HEK293 1.2 Low expression (non-muscle)
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.731G>A (p.Arg244His) Missense Common in TAAD Disrupts actin filament stability
c.536G>A (p.Arg179His) Missense Associated with Moyamoya Alters actin polymerization dynamics
c.445C>T (p.Arg149Cys) Missense Rare Impairs smooth muscle contraction
c.1A>G (p.Met1?) Start loss Very rare Complete loss of protein function
Mutation functional classification

Loss of Function (LOF)

Start-loss or nonsense mutations that abolish protein production, leading to haploinsufficiency.

Gain of Function (GOF)

Not typically described; most mutations are dominant-negative or loss-of-function.

Dominant Negative (DN)

Missense mutations (e.g., p.Arg244His, p.Arg179His) that produce defective actin monomers, interfering with filament assembly and contractile function.

Gene Ontology (GO)

• GO:0005524 - ATP binding • GO:0005200 - structural constituent of cytoskeleton
• GO:0006936 - muscle contraction • GO:0015629 - actin cytoskeleton
• GO:0030049 - muscle filament sliding • GO:0043231 - intracellular membrane-bounded organelle

Pathways

Smooth Muscle Contraction (Reactome: R-HSA-445355)
Actin Cytoskeleton Regulation (KEGG: hsa04810)
Vascular Smooth Muscle Contraction (KEGG: hsa04270)

Protein Summary

Alpha-actin-2 (UniProt P62736) is a 42 kDa protein composed of 377 amino acids. It forms the core of thin filaments in smooth muscle cells, providing structural support and enabling contraction via interaction with myosin. The protein is highly conserved and expressed predominantly in vascular and visceral smooth muscle. Mutations in ACTA2 compromise filament integrity, leading to vascular fragility and multisystemic smooth muscle dysfunction.

Related Products

Product name Cat.No. Species Gene ID
ACTA2 Knockout HEK293 Cell Line EDJ-KQ1463 Human 59 Details Get a Quote
ACTA2 Knockout HCT 116 Cell Line EDJ-KQ21027 Human 59 Details Get a Quote
ACTA2 Knockout HeLa Cell Line EDJ-KQ21028 Human 59 Details Get a Quote
ACTA2 Knockout A-549 Cell Line EDJ-KQ19690 Human 59 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: